|
WO2018051360A1
|
|
A novel process for the preparation of crystalline linezolid form-iii
|
|
AU2015376077A1
|
|
Novel process for the preparation of dipeptidyl peptidase-4 (DDP-4) enzyme inhibitor
|
|
WO2015068173A1
|
|
Novel oxazolidinone antibacterial compound
|
|
WO2015068171A1
|
|
Novel oxazolidinone compounds
|
|
WO2014102808A1
|
|
A process for preparation of trans (lr,2r)-cyclo hexane 1, 2-dicarboxylic acid
|
|
WO2014057495A1
|
|
A process for industrial preparation of [(s)-n-tert butoxycarbonyl-3-hydroxy]adamantylglycine
|
|
EP2593440A1
|
|
Anhydrous linezolid crystalline form-ii
|
|
CN103391927A
|
|
Novel process for preparation of linezolid and its novel intermediates
|
|
WO2007102167A1
|
|
A process for the preparation of anhydrous polymorphic form of olanzapine
|
|
WO2007096895A1
|
|
Preparation of anhydrous olanzapine of form-1
|
|
US2007191609A1
|
|
Process for preparation of clopidogrel bisulphate form-1
|
